Donor heart selection: the outcome of "unacceptable" donors

Noman H Khasati1, Ali Machaal, Jim Barnard

  • 1Cardiothoracic Surgery Department, Wythenshawe Hospital, Manchester, UK. nkhasati@yahoo.com

Insights

Donor hearts medically unsuitable at one UK center can be safely transplanted at others, expanding the organ pool. This study found no significant differences in outcomes for recipients of these hearts compared to standard donors.

Area of Science:

  • Cardiovascular Surgery
  • Transplantation Medicine
  • Organ Donation

Background:

  • Declining numbers of suitable donor hearts necessitate exploring previously unacceptable donors.
  • In the UK, donor hearts declined by one center may be offered to others.
  • This study evaluates outcomes of hearts deemed medically unsuitable by one center but transplanted by another.

Purpose of the Study:

  • To assess the safety and efficacy of transplanting donor hearts initially declined on medical grounds.
  • To determine if utilizing these hearts impacts recipient outcomes compared to standard donor hearts.
  • To evaluate the potential of expanding the donor heart pool through the use of previously rejected organs.

Main Methods:

  • A multi-center study comparing 93 donor hearts (Group A) transplanted after initial medical unsuitability with 723 standard donor hearts (Group B) transplanted in the UK (April 1998-March 2003).
  • Data sourced from the UK transplant database.
  • Comparative analysis using SPSS 11.5 for Windows.

Main Results:

  • Recipient characteristics were similar between Group A and Group B.
  • No significant differences observed in 30-day post-operative mortality, ICU/hospital stay, or cardiac cause of death.
  • Kaplan-Meier survival curves showed no significant difference in long-term survival (Log Rank test = 0.30).

Conclusions:

  • Donor hearts declined on medical grounds by one center can be safely transplanted and should be considered for national allocation.
  • The utilization of these hearts effectively expands the scarce donor pool.
  • There is no apparent justification for withholding this additional organ source from recipients.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...